Articles Tagged With:
-
REM Sleep Behavior Disorder and Biomarkers of Neurodegenerative Disease
Biomarkers for Parkinson's disease and related neurodegenerative diseases occur frequently in patients with idiopathic REM sleep behavior disorder. These include impairment of olfactory and color discrimination, and abnormalities in cerebral blood flow. -
Neurology Alert - Full July 2011 Issue in PDF
-
Clinical Briefs in Primary Care Supplement
-
Are We Close to Understanding the Role of Fingolimod in the Treatment of MS?
Patients originally on interferon beta-1a in the TRANSFORMS study were re-randomized to either 0.5 or 1.25 mg of fingolimod. There was a reduction in relapse rate and MRI activity in patients that switched to fingolimod without an increase in severe adverse events. -
Variant Creutzfeldt-Jakob Disease: A Review of 150 Cases
Variant Creutzfeldt-Jakob disease usually presents with subtle psychiatric symptoms and there is usually a significant delay in diagnosis. -
Bacterial Meningitis: Rarer, in Older Patients, but Equally Deadly
With the advent of new vaccines, the incidence of bacterial meningitis has declined, particularly in children, but the mortality rate has remained the same. -
Osteoporosis
Osteoporosis is a highly prevalent metabolic bone disease that affects both men and woman at risk of bone demineralization. -
Primary Care Reports - Full July 2011 Issue in PDF
-
NHLBI stops AIM-HIGH trial
Niacin may not be effective in preventing cardiovascular disease. -
Two new drugs for hepatitis C
The FDA has approved two new drugs for the treatment of hepatitis C the first new drugs to be approved in years.